Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE‐AD7

Baricitinib demonstrated efficacy in treating adults with moderate‐to‐severe atopic dermatitis (AD) in Phase 3 clinical trials.

[1]  J. Silverberg,et al.  Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis , 2021, Health and Quality of Life Outcomes.

[2]  S. Kwatra,et al.  Janus kinase inhibitors for atopic dermatitis: a promising treatment modality , 2021, Clinical and experimental dermatology.

[3]  T. Bieber,et al.  Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  J. Silverberg,et al.  Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials , 2020, The British journal of dermatology.

[5]  J. Silverberg,et al.  Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis , 2019, Journal of Patient-Reported Outcomes.

[6]  J. Silverberg Comorbidities and the impact of atopic dermatitis. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  E. Guttman‐Yassky,et al.  JAK Inhibitors for Atopic Dermatitis: An Update , 2018, American Journal of Clinical Dermatology.

[8]  D. Margolis,et al.  Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  A. Muraro,et al.  Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  J. Silverberg,et al.  Burden of skin pain in atopic dermatitis. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[12]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. , 2014, Journal of the American Academy of Dermatology.

[13]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. , 2014, Journal of the American Academy of Dermatology.

[14]  J. Ring,et al.  Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  H. Nakagawa,et al.  Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. , 2013, Journal of dermatological science.

[16]  K. H. Kim Overview of atopic dermatitis , 2013, Asia Pacific allergy.

[17]  J. Fridman,et al.  Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050 , 2010, The Journal of Immunology.

[18]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[19]  T. Jung New treatments for atopic dermatitis , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.